PE-526 Impaired Fasting Glycemia is a Silent Risk Factor of Target Vessel Revascularization in Patients Treated with a Sirolimus-eluting Stent(PE088,Coronary Revascularization, PCI (DES) 8 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)